Cargando…

ROR1 and ROR2 in Human Malignancies: Potentials for Targeted Therapy

Targeted therapies require cellular protein expression that meets specific requirements that will maximize effectiveness, minimize off-target toxicities, and provide an opportunity for a therapeutic effect. The receptor tyrosine kinase-like orphan receptors (ROR) are possible targets for therapy tha...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rebagay, Guilly, Yan, Su, Liu, Cheng, Cheung, Nai-Kong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Research Foundation 2012
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3356025/ https://www.ncbi.nlm.nih.gov/pubmed/22655270 http://dx.doi.org/10.3389/fonc.2012.00034

Ejemplares similares

Tyrosine Kinase ROR1 as a Target for Anti-Cancer Therapies
por: Zhao, Yuming, et al.
Publicado: (2021)

ROR1 and ROR2 expression in pancreatic cancer
por: Liu, Dongli, et al.
Publicado: (2021)

Targeting malignant B cells with an immunotoxin against ROR1
por: Baskar, Sivasubramanian, et al.
Publicado: (2012)

Digoxin, an Overlooked Agonist of RORγ/RORγT
por: Karaś, Kaja, et al.
Publicado: (2019)

RORγt and RORα signature genes in human Th17 cells
por: Castro, Glenda, et al.
Publicado: (2017)

RORα and RORγ expression inversely correlates with human melanoma progression
por: Brożyna, Anna A., et al.
Publicado: (2016)

Ror2 Signaling and Its Relevance in Breast Cancer Progression
por: Bayerlová, Michaela, et al.
Publicado: (2017)

Targeting the ROR1 and ROR2 receptors in epithelial ovarian cancer inhibits cell migration and invasion
por: Henry, Claire, et al.
Publicado: (2015)

A novel empeROR of pancreatic malignancy
por: Peñuelas‐Haro, Irene, et al.
Publicado: (2023)

New insights into the molecular mechanisms of ROR1, ROR2, and PTK7 signaling from the proteomics and pharmacological modulation of ROR1 interactome
por: Raivola, Juuli, et al.
Publicado: (2022)

Migration and invasion is inhibited by silencing ROR1 and ROR2 in chemoresistant ovarian cancer
por: Henry, C E, et al.
Publicado: (2016)

Construction and Stable Expression of a Truncated Human Receptor Tyrosine Kinase Ror1 (Ror1-ECD)
por: Forouzesh, Flora, et al.
Publicado: (2012)

Pan-Tissue and -Cancer Analysis of ROR1 and ROR2 Transcript Variants Identify Novel Functional Significance for an Alternative Splice Variant of ROR1
por: John, Miya, et al.
Publicado: (2022)

Evolutionary Divergence in the Catalytic Activity of the CAM-1, ROR1 and ROR2 Kinase Domains
por: Bainbridge, Travis W., et al.
Publicado: (2014)

Correction to: Migration and invasion is inhibited by silencing ROR1 and ROR2 in chemoresistant ovarian cancer
por: Henry, C. E., et al.
Publicado: (2022)

RORα Suppresses Epithelial-to-Mesenchymal Transition and Invasion in Human Gastric Cancer Cells via the Wnt/β-Catenin Pathway
por: Su, Jian, et al.
Publicado: (2019)

The Th17 immune response is controlled by the Rel–RORγ–RORγT transcriptional axis
por: Ruan, Qingguo, et al.
Publicado: (2011)

The Dichotomous Nature of AZ5104 (an EGFR Inhibitor) Towards RORγ and RORγT
por: Karaś, Kaja, et al.
Publicado: (2019)

Potential roles of ROR-α in cardiovascular endocrinology
por: Laitinen, Saara, et al.
Publicado: (2003)

Silencing ROR1 and ROR2 inhibits invasion and adhesion in an organotypic model of ovarian cancer metastasis
por: Henry, Claire, et al.
Publicado: (2017)

ROR1: an orphan becomes apparent
por: Kipps, Thomas J.
Publicado: (2022)

High expression level of ROR1 and ROR1-signaling associates with venetoclax resistance in chronic lymphocytic leukemia
por: Ghia, Emanuela M., et al.
Publicado: (2022)

The therapeutic potential of RORγ modulators in the treatment of human disease
por: Chang, Mi Ra, et al.
Publicado: (2012)

ROR: Nuclear Receptor for Melatonin or Not?
por: Ma, Haozhen, et al.
Publicado: (2021)

The application of machine learning methods to the prediction of novel ligands for RORγ/RORγT receptors
por: Bachorz, Rafał A., et al.
Publicado: (2023)

Therapeutic Potential and Challenges of Targeting Receptor Tyrosine Kinase ROR1 with Monoclonal Antibodies in B-Cell Malignancies
por: Yang, Jiahui, et al.
Publicado: (2011)

IGFBP5 is an ROR1 ligand promoting glioblastoma invasion via ROR1/HER2-CREB signaling axis
por: Lin, Weiwei, et al.
Publicado: (2023)

Distinct Patterns of Stromal and Tumor Expression of ROR1 and ROR2 in Histological Subtypes of Epithelial Ovarian Cancer()
por: Henry, CE, et al.
Publicado: (2017)

Wnt5a induces ROR1 and ROR2 to activate RhoA in esophageal squamous cell carcinoma cells
por: Wu, Xuping, et al.
Publicado: (2019)

Silencing RORγt in Human CD4(+) T cells with CD30 aptamer-RORγt shRNA Chimera
por: Shi, Xiaofei, et al.
Publicado: (2019)

Functional Variants in Linc-ROR are Associated with mRNA Expression of Linc-ROR and Breast Cancer Susceptibility
por: Luo, Chenglin, et al.
Publicado: (2018)

Distinct functions and prognostic values of RORs in gastric cancer
por: Gu, Feng, et al.
Publicado: (2020)

Rorα is essential for nuocyte development
por: Wong, See Heng, et al.
Publicado: (2012)

RORγ Structural Plasticity and Druggability
por: Huang, Mian, et al.
Publicado: (2020)

RORα, a Potential Tumor Suppressor and Therapeutic Target of Breast Cancer
por: Du, Jun, et al.
Publicado: (2012)

RORα controls inflammatory state of human macrophages
por: Nejati Moharrami, Neda, et al.
Publicado: (2018)

Extracellular vesicle-associated tyrosine kinase-like orphan receptors ROR1 and ROR2 promote breast cancer progression
por: Irmer, Barnabas, et al.
Publicado: (2023)

ROR1 Potentiates FGFR Signaling in Basal-Like Breast Cancer
por: Pandey, Gaurav, et al.
Publicado: (2019)

Inhibition of the Receptor Tyrosine Kinase ROR1 by Anti-ROR1 Monoclonal Antibodies and siRNA Induced Apoptosis of Melanoma Cells
por: Hojjat-Farsangi, Mohammad, et al.
Publicado: (2013)

ROR2 Is Epigenetically Regulated in Endometrial Cancer
por: Liu, Dongli, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_qoebr628qovhpqgk0svmtje3f3